State, formerly known as Reform, has recently published a report titled “Hospital of the future. Ending the patient gridlock.” Its most striking recommendation is that, in order to improve the flow of ...

The prolonged recovery has fueled speculation among fans that the injury could push LeBron James toward retirement.

Diagnosing heart failure in women can be particularly challenging. New research on biomarkers may lead to more accurate ...

Eli Lilly and Johnson & Johnson are joining fellow Big Pharma peers in upping their investment in AI, with Lilly looking to ...

Lisa LeCointe-Cephas has come full circle as chief compliance officer at Johnson & Johnson Innovative Medicine, the health ...

Johnson & Johnson JNJ and Merck MRK are leading U.S. healthcare giants, making them natural peers for a head-to-head ...

The Los Angeles Lakers wrapped up their preseason schedule Friday evening — losing to the Sacramento Kings by a score of 117-116. Not that it matters all that much, but the Lakers finished the ...

The Minnesota Vikings made an interesting quarterback move ahead of a Week 7 matchup with the Philadelphia Eagles. After taking over for an injured J.J. McCarthy in Week 3, Carson Wentz has gone 2-1 ...

Limited data are available on survival outcomes after sentinel-lymph-node biopsy alone as compared with lymphadenectomy in cervical cancer. In this multicenter, randomized, noninferiority trial, we ...

Telitacicept, a new dual inhibitor of the cytokines B-lymphocyte stimulator (BLyS) and APRIL (a proliferation-inducing ligand), showed efficacy in adults with active systemic lupus erythematosus (SLE) ...

NEW YORK – Johnson & Johnson's treatment combining Rybrevant (amivantamab) and Lazcluze (lazertinib) is giving AstraZeneca's Tagrisso (osimertinib) competition in the first-line EGFR-mutated non-small ...

Johnson & Johnson said Tuesday that it plans to spin out its orthopedics business, creating a standalone company that would compete with firms like Stryker and Zimmer Biomet. The healthcare giant said ...